Paravasthu Mukund - Nov 1, 2024 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Operating Officer
Signature: Ovie Onobrakpeya, as attorney in fact for Paravasthu, Mukund
Stock symbol: NVCR
Transactions as of: Nov 1, 2024
Transactions value $: -$2,540
Form type: 4
Date filed: 11/4/2024, 04:32 PM
Previous filing: Oct 9, 2024
Next filing: Nov 6, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Sale	-$2.54K	-160	-4.37%	$15.88	3.5K	Nov 1, 2024	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F2	This transaction was executed in multiple trades at prices ranging from $15.80 USD to $15.94 USD; the price reported above reflects the weighted average sale price.

Content

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

This transaction was executed in multiple trades at prices ranging from $15.80 USD to $15.94 USD; the price reported above reflects the weighted average sale price.